Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up

Liver International

Volumn 30, Issue 2, 2010, Pages 251-258

  Björnsson, Einar ^a   Kalaitzakis, Evangelos ^a   Neuhauser, Matthias ^a   Enders, Felicity ^b   Maetzel, Hardy ^a   Chapman, Roger W ^a   Talwalkar, Jayant ^b   Lindor, Keith ^b   Jorgensen, Roberta ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAYO CLINIC   (United States)

Author keywords

Fatigue; Liver cirrhosis; Liver transplantation; Primary biliary cirrhosis; Prognosis

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FATIGUE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; SCORING SYSTEM; SURVIVAL;

AGED; COMORBIDITY; FATIGUE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MINNESOTA; PROGNOSIS; SICKNESS IMPACT PROFILE; SURVIVAL RATE; SWEDEN;

EID: 77950625500     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02160.x     Document Type: Article

References (23)

1. Christensen E, Crowe J, Doniach D. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980, 78:236-46.
2. James O, Macklon AF, Watson AJ. Primary biliary cirrhosis - a revised clinical spectrum. Lancet 1981, 1:1278-81.
3. Witt-Sullivan H, Heathcote J, Cauch K. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 1990, 12:98-105.
4. Cauch-Dudek K, Abbey S, Stewart DE. Fatigue in primary biliary cirrhosis. Gut 1998, 43:705-10.
5. Huet PM, Deslauriers J, Tran A. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000, 95:760-7.
6. Prince MI, James OF, Holland NP. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000, 32:368-73.
7. Goldblatt J, Taylor PJ, Lipman T. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002, 122:1235-41.
8. Stanca CM, Bach N, Krause C. Evaluation of fatigue in US patients with primary biliary cirrhosis. Am J Gastroenterol 2005, 100:1104-9.
9. Bjornsson E, Simren M, Olsson R. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005, 17:351-7.
10. Theal JJ, Toosi MN, Girlan L. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue. Hepatology 2005, 41:1305-12.
11. Talwalkar JA, Donlinger JJ, Gossard AA. Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. Dig Dis Sci 2006, 51:1985-91.
12. Biagini MR, Tozzi A, Milani S. Fatigue in primary biliary cirrhosis: a possible role of comorbidities. Eur J Gastroenterol Hepatol 2008, 20:122-6.
13. Newton JL. Fatigue in primary biliary cirrhosis. Clin Liver Dis 2008, 12:367-83. ix
14. Blackburn P, Freeston M, Baker CR. The role of psychological factors in the fatigue of primary biliary cirrhosis. Liver Int 2007, 27:654-61.
15. Jones DE, Bhala N, Burt J. Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut 2006, 55:536-41.
16. Zein CO, McCullough AJ. Association between fatigue and decreased survival in primary biliary cirrhosis. Gut 2007, 56:1165-6. author reply 1166
17. Fisk JD, Ritvo PG, Ross L. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994, 18((Suppl. 1)):S79-83.
18. Crippin JS, Lindor KD, Jorgensen R. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1992, 15:858-62.
19. Van Dam GM, Gips CH. Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures. Scand J Gastroenterol 1997, 32:77-83.
20. Longo M, Crosignani A, Battezzati PM. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002, 51:265-9.
21. Prince MI, Chetwynd A, Craig WL. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 2004, 53:865-70.
22. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997, 337:473-9.
23. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986, 3:75-82.